Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2019
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell TransplantationHaitham Abdelhakim, Leyla Shune, Sajjad Bhatti, et al.Archives of Pathology & Laboratory Medicine|August 4, 2021
Laboratory Detection and Initial Diagnosis of Monoclonal GammopathiesDavid F Keren, Gregary Bocsi, Brooke L Billman, et al.British Journal of Pharmacology|September 3, 2020
Bisphosphonates for delivering drugs to boneShuting Sun, Jianguo Tao, Parish P Sedghizadeh, et al.The Lancet. Haematology|December 28, 2020
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trialSaad Z Usmani, Antje Hoering, Sikander Ailawadhi, et al.Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With TalquetamabAjai Chari, Amrita Krishnan, Leo Rasche, et al.Blood|October 21, 2016
Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationOmar S Aljitawi, Soumen Paul, Avishek Ganguly, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice GuidelineJoseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living GuidelineLisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.Cancer Medicine|October 2, 2025
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple MyelomaNiels W C J van de Donk, Ajai Chari, Thomas Martin, et al.Pageof 3